167 related articles for article (PubMed ID: 24071599)
1. Interpreting patient treatment response in analgesic clinical trials: implications for genotyping, phenotyping, and personalized pain treatment.
Dworkin RH; McDermott MP; Farrar JT; O'Connor AB; Senn S
Pain; 2014 Mar; 155(3):457-460. PubMed ID: 24071599
[No Abstract] [Full Text] [Related]
2. Pharmacogenetics and Personalized Medicine in Pain Management.
Webster LR; Belfer I
Clin Lab Med; 2016 Sep; 36(3):493-506. PubMed ID: 27514464
[TBL] [Abstract][Full Text] [Related]
3. Emerging targets and therapeutic approaches for the treatment of osteoarthritis pain.
Rahman W; Dickenson AH
Curr Opin Support Palliat Care; 2015 Jun; 9(2):124-30. PubMed ID: 25730180
[TBL] [Abstract][Full Text] [Related]
4. A critical appraisal of human genotyping for pain therapy.
Lötsch J; Geisslinger G
Trends Pharmacol Sci; 2010 Jul; 31(7):312-7. PubMed ID: 20483491
[TBL] [Abstract][Full Text] [Related]
5. Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations.
Edwards RR; Dworkin RH; Turk DC; Angst MS; Dionne R; Freeman R; Hansson P; Haroutounian S; Arendt-Nielsen L; Attal N; Baron R; Brell J; Bujanover S; Burke LB; Carr D; Chappell AS; Cowan P; Etropolski M; Fillingim RB; Gewandter JS; Katz NP; Kopecky EA; Markman JD; Nomikos G; Porter L; Rappaport BA; Rice ASC; Scavone JM; Scholz J; Simon LS; Smith SM; Tobias J; Tockarshewsky T; Veasley C; Versavel M; Wasan AD; Wen W; Yarnitsky D
Pain; 2016 Sep; 157(9):1851-1871. PubMed ID: 27152687
[TBL] [Abstract][Full Text] [Related]
6. Evidence-based clinical trial design for chronic pain pharmacotherapy: a blueprint for ACTION.
Dworkin RH; Turk DC; Katz NP; Rowbotham MC; Peirce-Sandner S; Cerny I; Clingman CS; Eloff BC; Farrar JT; Kamp C; McDermott MP; Rappaport BA; Sanhai WR
Pain; 2011 Mar; 152(3 Suppl):S107-S115. PubMed ID: 21145657
[No Abstract] [Full Text] [Related]
7. [Pharmacogenetic use in clinical practice: treatment of pain].
Peiró Peiró AM
Med Clin (Barc); 2013 Dec; 141(11):501-6. PubMed ID: 24216014
[No Abstract] [Full Text] [Related]
8. Personalizing pediatric pain medicine: using population-specific pharmacogenetics, genomics, and other -omics approaches to predict response.
Jimenez N; Galinkin JL
Anesth Analg; 2015 Jul; 121(1):183-187. PubMed ID: 26086515
[TBL] [Abstract][Full Text] [Related]
9. Towards personalized treatment of pain using a quantitative systems pharmacology approach.
Goulooze SC; Krekels EHJ; van Dijk M; Tibboel D; van der Graaf PH; Hankemeier T; Knibbe CAJ; van Hasselt JGC
Eur J Pharm Sci; 2017 Nov; 109S():S32-S38. PubMed ID: 28506867
[TBL] [Abstract][Full Text] [Related]
10. A pharmacogenetics approach to pain management.
Yoshida K; Nishizawa D; Ide S; Ichinohe T; Fukuda KI; Ikeda K
Neuropsychopharmacol Rep; 2018 Mar; 38(1):2-8. PubMed ID: 30106264
[TBL] [Abstract][Full Text] [Related]
11. Genetic variability of pain perception and treatment--clinical pharmacological implications.
Lötsch J
Eur J Clin Pharmacol; 2011 Jun; 67(6):541-51. PubMed ID: 21344316
[TBL] [Abstract][Full Text] [Related]
12. [MODERN VIEWS ON THE PHARMACOGENETICS OF PAIN.].
Makharin OA; Zhenilo VM; Patyuchenko OY
Anesteziol Reanimatol; 2017 Sep; 61():219-223. PubMed ID: 29465208
[TBL] [Abstract][Full Text] [Related]
13. To Genotype or Phenotype for Personalized Medicine? CYP450 Drug Metabolizing Enzyme Genotype-Phenotype Concordance and Discordance in the Ecuadorian Population.
De Andrés F; Terán S; Hernández F; Terán E; LLerena A
OMICS; 2016 Dec; 20(12):699-710. PubMed ID: 27849442
[TBL] [Abstract][Full Text] [Related]
14. Lessons from Cuba for Global Precision Medicine: CYP2D6 Genotype Is Not a Robust Predictor of CYP2D6 Ultrarapid Metabolism.
Dorado P; González I; Naranjo ME; de Andrés F; Peñas-Lledó EM; Calzadilla LR; LLerena A
OMICS; 2017 Jan; 21(1):17-26. PubMed ID: 28271978
[TBL] [Abstract][Full Text] [Related]
15. Statistical pitfalls of personalized medicine.
Senn S
Nature; 2018 Nov; 563(7733):619-621. PubMed ID: 30482931
[No Abstract] [Full Text] [Related]
16. Navigating trials of personalized pain treatments: we're going to need a bigger boat.
Gewandter JS; McDermott MP; Mbowe O; Edwards RR; Katz NP; Turk DC; Dworkin RH
Pain; 2019 Jun; 160(6):1235-1239. PubMed ID: 30694930
[No Abstract] [Full Text] [Related]
17. CYP450 Genotype/Phenotype Concordance in Mexican Amerindian Indigenous Populations-Where to from Here for Global Precision Medicine?
de Andrés F; Sosa-Macías M; Ramos BPL; Naranjo MG; LLerena A
OMICS; 2017 Sep; 21(9):509-519. PubMed ID: 28873029
[TBL] [Abstract][Full Text] [Related]
18. Personalized Medicine: Genomics Trials in Oncology.
Hayes DF; Schott AF
Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
[TBL] [Abstract][Full Text] [Related]
19. Assessment of analgesic drugs.
Dundee JW; Loan WB
Pharmacol Ther; 1981; 12(3):589-98. PubMed ID: 7025034
[No Abstract] [Full Text] [Related]
20. Personalized Perioperative Pediatric Pain Management: Myth or Reality?
Mele C; Goldschmidt K
J Pediatr Nurs; 2017; 32():85-87. PubMed ID: 27890527
[No Abstract] [Full Text] [Related]
[Next] [New Search]
